MAGOHB expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 9.632600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
8.677400E-01
Normal-vs-Stage2
9.842400E-01
Normal-vs-Stage3
8.584400E-01
Normal-vs-Stage4
8.894800E-01
Stage1-vs-Stage2
8.886600E-01
Stage1-vs-Stage3
8.246600E-01
Stage1-vs-Stage4
9.757000E-01
Stage2-vs-Stage3
8.659400E-01
Stage2-vs-Stage4
8.931800E-01
Stage3-vs-Stage4
8.156400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
9.208800E-01
Normal-vs-AfricanAmerican
8.115400E-01
Normal-vs-Asian
3.537000E-01
Caucasian-vs-AfricanAmerican
8.173600E-01
Caucasian-vs-Asian
1.867640E-01
AfricanAmerican-vs-Asian
2.170400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
9.974800E-01
Normal-vs-Female
8.940600E-01
Male-vs-Female
5.943600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.842200E-01
Normal-vs-Age(41-60Yrs)
7.690400E-01
Normal-vs-Age(61-80Yrs)
8.998200E-01
Normal-vs-Age(81-100Yrs)
3.514000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
6.280600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.479800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
2.300000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.404970E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
4.977800E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
1.318390E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
8.935400E-01
Normal-vs-Daily Drinker
6.981800E-01
Normal-vs-Weekly Drinker
6.371800E-01
Normal-vs-Occasional Drinker
6.199800E-01
Normal-vs-Social Drinker
7.718600E-01
Non Drinker-vs-Daily Drinker
3.176200E-01
Non Drinker-vs-Weekly Drinker
4.686600E-01
Non Drinker-vs-Occasional Drinker
5.144000E-01
Non Drinker-vs-Social Drinker
8.578800E-01
Daily Drinker-vs-Weekly Drinker
1.215800E-01
Daily Drinker-vs-Occasional Drinker
9.882300E-02
Daily Drinker-vs-Social Drinker
2.324200E-01
Weekly Drinker-vs-Occasional Drinker
8.700200E-01
Weekly Drinker-vs-Social Drinker
5.874400E-01
Occasional Drinker-vs-Social Drinker
6.430400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
9.864800E-01
Normal-vs-Grade 2
9.949600E-01
Normal-vs-Grade 3
8.809800E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
7.541800E-01
Grade 1-vs-Grade 3
9.524500E-02
Grade 1-vs-Grade 4
9.864800E-01
Grade 2-vs-Grade 3
5.330400E-02
Grade 2-vs-Grade 4
9.949600E-01
Grade 3-vs-Grade 4
8.809800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
7.309800E-01
Normal-vs-NonDiabetic
8.327400E-01
Diabetic-vs-NonDiabetic
1.016040E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
9.581200E-01
Normal-vs-NoPancreatitis
9.290200E-01
Pancreatitis-vs-NoPancreatitis
9.324800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
7.900200E-01
Normal-vs-N1
9.797200E-01
N0-vs-N1
3.667800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
5.110800E-01
Normal-vs-TP53-NonMutant
8.775200E-01
TP53-Mutant-vs-TP53-NonMutant
4.802100E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
